FIELD: chemistry.
SUBSTANCE: invention relates to crystalline 1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)-ethyl]-3-(2-methylquinolin-4-yl)-urea of formula I
,
in monosulphate trihydrate form. The invention also relates to a composition based on the said compound which has antagonistic effect on urotensin.
EFFECT: obtaining a novel compound and compositions based on said compound, which can be used in medicine as neurohormonal antagonists.
8 cl, 3 dwg, 5 tbl, 5 ex
Authors
Dates
2010-08-27—Published
2005-10-11—Filed